Drug: Vyvanse (lisdexamfetamine dimesylate)
Company: New River Pharmaceuticals
Approval Date: 23-Feb-2007
Scoop: Vyvanse is amphetamine based, but only becomes effective after it enters the digestive tract. The company says that the digestive trigger mechanism should make the drug less liable for abuse by users who snort or inject pills.
FDA hands out two key regulatory approvals. Report